Impurity profile study of zaleplon

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 1, 2007, Pages 101-109

  Bharathi, Ch ^a   Prabahar, K Joseph ^a   Prasad, Ch S ^a   Kumar, M Saravana ^a   Magesh, S ^a   Handa, V K ^a   Dandala, Ramesh ^a   Naidu, A ^b  

^a APL Research Centre   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Characterization; Impurities; Isolation; Preparative HPLC; Zaleplon

Indexed keywords

ACETAMIDE DERIVATIVE; N (3 (3 (4 AMINO 2H PYRAZOLO [3,4 D]PYRIMIDIN 6 YL) PYRAZOLO[1,5 A] PYRIMIDIN 7 YL)PHENYL) N ETHYLACETAMIDE; N [3 (3 CARBOXAMIDOPYRAZOLO[1,5 A]PYRIMIDIN 7 YL}PHENYL] N ETHYLACETAMIDE; N [3 (3 CYANO 6 [(E) 3 ((N ETHYL N ACETYL)AMINO)PHENYL 3 OXOPROP 1 ENYL]PYRAZOLO[1,5 A]PYRIMIDIN 7 YL)PHENYL] N ETHYLACETAMIDE; N [3 (3 CYANOPYRAZOLO[1,5 A]PYRIMIDIN 7 YL)PHENYL]ACETAMIDE; N [3 (3 CYANOPYRAZOLO[1-5 A]PYRIMIDIN 5 YL)PHENYL] N ETHYLACETAMIDE; N [3 (CYANOPYRAZOLO [1,5 A]PYRIMIDIN 7 YL)PHENYL] N METHYLACETAMIDE; UNCLASSIFIED DRUG; ZALEPLON;

ARTICLE; DRUG IMPURITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ACETAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; HYPNOTICS AND SEDATIVES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PYRIMIDINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSITION TEMPERATURE;

EID: 34047275405     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.01.051     Document Type: Article

References (10)

1. Deng M., Zhang S.F., Liu J.F., and Liu H.C. J. Yaowu Fenxi Zazhi 24 (2004) 611-613
2. Foda N.H., Abd Elbary A., and El-Gazayerly O. Anal. Lett. 39 (2006) 1891-1905
3. Horstkoetter C., Schepmann D., and Blaschke G. J. Chromatogr. A 1014 (2003) 71-81
4. Feng F., Jiang J.J., Dai H., and Wu J. J. Chromatogr. Sci. 41 (2003) 17-21
5. Zhang B., Zhang Z., Tian Y., Xu F., and Chen Y. J. Pharm. Biomed. Anal. 40 (2006) 707-714
6. Giroud C., Augsburger M., Menetrey A., and Mangin P. J. Chromatogr. B 789 (2003) 131-138
7. Li Q.C., Deng Z.X., and Chang J.L. Chin. Pharm. J. 39 (2004) 220-221
8. ICH Guideline Q3A (R), Impurities in New Drug Substances, 7 February, 2002.
9. F. Korodi, E. Feher, E. Magyar, International application published under the patent cooperation treaty (PCT), WO 02/100828, 19 December 2002.
10. M. Korycinska, T. Stawinski, M. Wieczorek, International application published under the patent cooperation treaty (PCT), WO 03/095456, 20 November 2003.